Journal profile · Clinical Neurology
Epilepsy Research
ISSN 0920-1211 · eISSN 1872-6844 · Elsevier · NETHERLANDS · Monthly
Epilepsy Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.28; hybrid open access; APC about USD 2,880; median 95 days to acceptance (108 articles, last 24 months); community-reported acceptance: easy; 151 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Epilepsy Research is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Epilepsy research and treatment, Neuroscience and Neuropharmacology Research and Pharmacological Effects and Toxicity Studies, together about 58.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Epilepsy Research provides for publication of high quality articles in both basic and clinical epilepsy research, with a special emphasis on translational research that ultimately relates to epilepsy as a human condition. The journal is intended to provide a forum for reporting the best and most rigorous epilepsy research from all disciplines ranging from biophysics and molecular biology to epidemiological and psychosocial research. As such the journal will publish original papers relevant to epilepsy from any scientific discipline and also studies of a multidisciplinary nature. Clinical and experimental research papers adopting fresh conceptual approaches to the study of epilepsy and its treatment are encouraged. The overriding criteria for publication are novelty, significant clinical or experimental relevance, and interest to a multidisciplinary audience in the broad arena of epilepsy. Review articles focused on any topic of epilepsy research will also be considered, but only if they present an exceptionally clear synthesis of current knowledge and future directions of a research area, based on a critical assessment of the available data or on hypotheses that are likely to stimulate more critical thinking and further advances in an area of epilepsy research.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Kelly KnuppPublisher website
Editorial board by country: 6 in mainland China (about 13%); most named United States 19, Mainland China 6, Australia 6, United Kingdom 3, Italy 3 (46 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Epilepsy research and treatmentMedicine30.1%
- Neuroscience and Neuropharmacology ResearchNeuroscience16.2%
- Pharmacological Effects and Toxicity StudiesMedicine12.3%
- EEG and Brain-Computer InterfacesNeuroscience4.4%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology3.7%
- Functional Brain Connectivity StudiesNeuroscience2.8%
- Neurological disorders and treatmentsMedicine2.6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.28LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 0.78LetPub ·
- h-index
- 105LetPub ·
- h-index
- 160OpenAlex ·
- i10-index
- 4,010OpenAlex ·
- 2-year mean citedness
- 2.07OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 21.36%LetPub ·
Volume
- Articles per year
- 130LetPub ·
Articles by year OpenAlex count · 6,042 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 154 | 45 | 26 |
| 2025 | 151 | 55 | 300 |
| 2024 | 143 | 54 | 600 |
| 2023 | 149 | 61 | 1,070 |
| 2022 | 152 | 47 | 1,517 |
| 2021 | 243 | 64 | 3,005 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
95 daysMedian, submission to acceptance · P25–P75 76 days – 129 days
- Acceptance to online
- median 2 days (108 articles)
- Submission to online
- median 98 days
- Sample
- 108 articles with submission and acceptance dates (318 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 92 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,880 / EUR 2,690 / GBP 2,310 / JPY 357,210 | — | — | |
| Publisher website | USD 3,320 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 1,500 words
- Reference style
- Author–date
- Highlights
- Required
- Not considered
- case reports
Article types accepted10, with length limits
- case reportThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…Length not stated
- full-length papersFull-length Papers: giving findings of original basic or clinical research in any area of epilepsy within the scope of the journal.Length not stated
- hypothesisThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…Length not stated
- letters to the editorThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…Length not stated
- original articleThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…Length not stated
- reviewThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…Length not stated
- review articleThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…Length not stated
- review articlesReview Articles: on specialised topics within the scope of the journal. Prospective authors should contact the Editor-in-Chief or one of the Associate Editors b…Length not stated
- short communicationThe journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. In general, it the policy of Epile…main text ≤ 1,500 words
- short communicationsShort Communications: 1,500 words plus no more than 3 figures or tables in total 20 references.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Monthly
- ISSN
- 0920-1211
- Electronic ISSN
- 1872-6844
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Epilepsy Research
What CAS zone is Epilepsy Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Epilepsy Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Epilepsy Research?
The latest impact factor listed by LetPub is 2.28; CiteScore 4.1, h-index 160.
How long does peer review take at Epilepsy Research?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 76–129 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Epilepsy Research?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 1,500 words; Reference style: Author–date; Highlights: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Epilepsy Research based?
Of the 46 board members whose country the journal's board page names, 6 (about 13%) are in mainland China; the countries named most often are United States (19), Mainland China (6) and Australia (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Epilepsy Research?
According to LetPub and DOAJ records, Epilepsy Research is indexed in SCIE and Scopus.
Is Epilepsy Research open access, and what is the APC?
Epilepsy Research is a hybrid journal. For open-access publication: APC about USD 2,880.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .